Fertility clinic in northern Cyprus accused of swapping donor genetic material

A growing scandal has emerged over a fertility

A growing scandal has emerged over a fertility facility in northern Cyprus, where numerous families now suspect that the sperm and eggs used in their treatment did not match the donors they had explicitly chosen. The allegations, which have sparked profound distress among affected parents, suggest that the clinic may have systematically misrepresented the origins of the genetic material used in IVF procedures.

According to testimony gathered from several couples, they were led to believe that they were receiving gametes from specific, vetted donors—often selected for physical traits or medical history—only to later discover discrepancies in the children’s characteristics or through DNA testing. In some cases, parents have reported that the donors they believed were involved had no record of ever donating at the clinic, while other individuals appear to have been used without their knowledge.

The clinic, which has not been named publicly due to ongoing investigations, reportedly marketed itself to international clients, including many from the UK, as a reliable and affordable option for fertility treatment. However, a whistleblower inside the operation has claimed that staff were instructed to substitute donors when the preferred ones were unavailable, without informing the patients. This practice, if confirmed, would constitute a serious breach of medical ethics and UK regulations on cross-border reproductive care.

Medical experts have warned that such mismatches carry

Medical experts have warned that such mismatches carry significant psychological and legal implications for families, including issues of inheritance, identity, and the right to know one’s biological origins. The UK’s fertility regulator has stated that it is in contact with authorities in Cyprus and is urging affected British nationals to come forward with any documentation or DNA evidence. Meanwhile, legal action is being considered by some parents, who argue that the clinic’s actions amount to fraud and negligence.

For those involved, the emotional toll is immense. One mother, speaking on condition of anonymity, described the revelation as "a complete betrayal of trust," explaining that her family had chosen a donor with a specific ethnic background to ensure cultural continuity, only to discover that the child was conceived with material from an entirely different source. She called for a full independent audit of all patients treated at the facility since its opening.

As the investigation continues, experts are urging prospective parents to verify the credentials of any overseas clinic and to request independent genetic profiling of embryos before implantation. The case has also reignited calls for tighter international oversight of cross-border fertility services, which currently operate in a regulatory grey area for UK residents seeking treatment abroad.